Cder compounding center of excellence (COE)
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40120C00160
- Awardee
-
Deloitte Consulting LLP UEI CKV2L9GZKJK3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $21,997,249
Award facts
- Opportunity
-
- Engagement with Compounding Outsourcing Facilities Pre-Solicitation · FDARFP1223623 · Posted Apr 17, 2020
- Engagement with Compounding Outsourcing Facilities Award Notice · Posted Sep 29, 2020
- Engagement with Compounding Outsourcing Facilities Solicitation · Posted Jul 21, 2020
- Contract value 89% obligated
-
- $21,997,249.38 Current, with exercised options
- $24,732,278.06 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Time and Materials
- Place of performance
- Arlington, VA 22209, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,106,912 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,049,082 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $4,948,999 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $6,759,607 | |
| Other Administrative Action | $561,373 | |
| Original award | $5,571,276 |
Show all 13
About this award
This is a $24,732,278.06 definitive contract awarded by the Food and Drug Administration (FDA) to Deloitte Consulting LLP to establish and operate the CDER Compounding Center of Excellence (COE). The contract is a time and materials type and has an ultimate completion date of March 29, 2026.
The COE will provide in-person and online trainings, host an annual conference, perform evaluations and assessments, develop a training roadmap, and advance initiatives to ensure drug safety and public health regarding compounded drugs and outsourcing facilities. The contract was initially set aside for small businesses, but no set-aside was ultimately used. Deloitte has enlisted several subcontractors, including Genesis Engineers Inc., Cine-Med Incorporated, and Parenteral Drug Association Inc., to support the COE's work.
Quick answers
Who was awarded contract 75F40120C00160?
75F40120C00160 was awarded to Deloitte Consulting LLP by Food and Drug Administration (Department of Health and Human Services) on September 29, 2020.
How much is contract 75F40120C00160 worth?
The government has obligated $21,997,249 on 75F40120C00160. Its potential value, with all options, is $24,732,278.
Was contract 75F40120C00160 competed?
The extent of competition for 75F40120C00160 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award